Tritium Production for the U.S. Nuclear Weapons Program:An Analysis of Key Issues
2000-06-16
org.kosen.entty.User@6c5cc934
운영자(kosenadmin)
행사&학회소개
보고서작성신청
1999년 4월에 발간된 미의회 보고서(Congressional Research Service Report for Congress)로 전체 37쪽 분량입니다. 5~7쪽으로 요약분석하실 분은 신청해주시기 바랍니다. 원문은 Multi TIF 파일로 작성되어 있습니다.
Abstract :
On December 22, 1998, the Department of Energy(DOE) announced its selection of the Tennessee Valley Authority's(TVA) Watts Bar and Sequoyah nuclear power plants to supply irradiation services to replenish tritium lost due to radioactive decay in the nation's stockpile of nuclear weapons. Seviral key issues remain, however, that are likely to be of concern to the Congress as it reviews DOE's tritium production program during consideration of the FY2000 defense authorization bill, and the FY2000 energy and water development appropriations bill. Questions about the costs of the various options, including the potential for offsetting revenues resulting from medical isotope production and accelerator transmutation of nuclear waste, do not appear to have been completely addressed. In addtion, concerns remain about whether use of a commercial nuclear power plant to produce tritium for weapons purposes constitutes a nuclear proliferation risk. This report addresses these issues. It supplements CRS Issue Brief 97002, The Department of Energy's Tritium Production Program. The report should be useful to Members and staff in considering the DOE tritium production program. The report will be updated as legislative and DOE actions dictate.
Abstract :
On December 22, 1998, the Department of Energy(DOE) announced its selection of the Tennessee Valley Authority's(TVA) Watts Bar and Sequoyah nuclear power plants to supply irradiation services to replenish tritium lost due to radioactive decay in the nation's stockpile of nuclear weapons. Seviral key issues remain, however, that are likely to be of concern to the Congress as it reviews DOE's tritium production program during consideration of the FY2000 defense authorization bill, and the FY2000 energy and water development appropriations bill. Questions about the costs of the various options, including the potential for offsetting revenues resulting from medical isotope production and accelerator transmutation of nuclear waste, do not appear to have been completely addressed. In addtion, concerns remain about whether use of a commercial nuclear power plant to produce tritium for weapons purposes constitutes a nuclear proliferation risk. This report addresses these issues. It supplements CRS Issue Brief 97002, The Department of Energy's Tritium Production Program. The report should be useful to Members and staff in considering the DOE tritium production program. The report will be updated as legislative and DOE actions dictate.